Ivermectin for COVID-19: Concerns during pregnancy.

Wise, L David; Scialli, Anthony R

Wise, L David; Scialli, Anthony R.

Wise LD; Merck Research Laboratories (retired), 200 W. Washington Square, Philadelphia, PA, United States. Electronic address: l.david.wise@gmail.com.
Scialli AR; Scialli Consulting LLC, 2737 Devonshire Pl NW #120, Washington DC, 20008-3459, United States. Electronic address: ascialli@scialliconsulting.com.

Reprod Toxicol ; 107: 43, 2022 01.

Article in English | MEDLINE | ID: covidwho-1527840

Subject(s)

COVID-19; Ivermectin; Female; Humans; Ivermectin/toxicity; Pregnancy; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ivermectin / COVID-19 Limits: Female / Humans / Pregnancy Language: English Journal: Reprod Toxicol Journal subject: Embryology / Reproductive Medicine / Toxicology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google